06 Jun

GoodGut abre una ronda de financiación en Capital Cell para ultimar su test de cáncer colorrectal

GoodGut abre una ronda de financiación en Capital Cell para ultimar su test de cáncer colorrectal

INVIERTE GoodGut celebra su quinto aniversario con varios hitos empresariales, médicos y científicos logrados. Con la mirada puesta en finalizar la validación clínica del RAID-CRC, el primer test no invasivo para el diagnóstico precoz del cáncer colorrectal a partir de la microbiota intestinal, la empresa biotecnológica acaba de poner en marcha una ampliación de capital […]

23 Apr

GoodGut signs an agreement with Palex to launch first non-invasive diagnostic tests for IBS and IBD

GoodGut signs an agreement with Palex to launch first non-invasive diagnostic tests for IBS and IBD

GoodGut has signed an agreement with Palex Medical to start selling its new non-invasive diagnostic tests RAID-Dx for irritable bowel syndrome (IBS) and RAID-Monitor for inflammatory bowel disease (IBD) in Spain. These are the first products developed by GoodGut to reach the patient after ten years of R&D and clinical validation with internationally prestigious digestive […]

06 Dec

Mariona Serra receives the Fidem award for innovation

Mariona Serra receives the Fidem award for innovation

The co-founder and CEO of GoodGut, Mariona Serra, was honoured with the Fidem 2018 award for innovation at a gala held on 29 November in CaixaFòrum Barcelona. Serra received the award from the Catalan Minister of the Presidency, Elsa Artadi, who took part in the event alongside the Minister of Enterprise and Knowledge, Àngels Chacón. […]

17 Apr

Doctor Julià Panés joins the GoodGut Board of Advisors

Doctor Julià Panés joins the GoodGut Board of Advisors

GoodGut has a new member of its Board of Advisors: Dr Julià Panés, a well-known specialist in inflammatory bowel disease (IBD). Panés is the director of the IBD research group at the August Pi i Sunyer Biomedical Research Institute (Idibaps) and head of the IBD Unit at Barcelona’s Hospital Clínic. His team publishes an average of […]